Miscellaneous News

RSS
How women in England faced childbirth in the COVID-19 pandemic

How women in England faced childbirth in the COVID-19 pandemic

Study explores contemporary attitudes towards wealth transfer taxation in Australia

Study explores contemporary attitudes towards wealth transfer taxation in Australia

UK study finds SARS-CoV-2 antibodies in domestic cats and dogs

UK study finds SARS-CoV-2 antibodies in domestic cats and dogs

Nanotechnology and artificial intelligence may be valuable components in securing global food production

Nanotechnology and artificial intelligence may be valuable components in securing global food production

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

What impacts public compliance with COVID-19 restrictions?

What impacts public compliance with COVID-19 restrictions?

Does SARS-CoV-2 show seasonal variation in transmission in temperate countries?

Does SARS-CoV-2 show seasonal variation in transmission in temperate countries?

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

A closer look at how COVID-19 damages human lungs

A closer look at how COVID-19 damages human lungs

Could the intranasal route be an alternate avenue of COVID-19 vaccination?

Could the intranasal route be an alternate avenue of COVID-19 vaccination?

Iksuda Therapeutics closes $47 million financing round

Iksuda Therapeutics closes $47 million financing round

Compelling evidence of SARS-CoV-2 exposure and neutralizing antibodies in domestic cats in Peru

Compelling evidence of SARS-CoV-2 exposure and neutralizing antibodies in domestic cats in Peru

Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model

Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

Study offers longitudinal roadmap of immune activation and resolution in mild COVID-19

Study offers longitudinal roadmap of immune activation and resolution in mild COVID-19

Researchers repurpose pre-existing anti-SARS-CoV antibody to develop potent neutralizing antibody against SARS-CoV-2

Researchers repurpose pre-existing anti-SARS-CoV antibody to develop potent neutralizing antibody against SARS-CoV-2

Could a mathematical application of information theory identify and predict SARS-CoV-2 mutations?

Could a mathematical application of information theory identify and predict SARS-CoV-2 mutations?

Inflammatory brain injury higher in men with acute COVID-19, finds study

Inflammatory brain injury higher in men with acute COVID-19, finds study